Publication Name	World Journal of Gastroenterology
Manuscript ID	70494
Country	Singapore

Received	2021-08-05 14:54
Peer-Review Started	2021-08-05 14:59
To Make the First Decision
Return for Revision	2021-09-04 01:28
Revised	2021-09-15 07:30
Second Decision	2022-05-13 02:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-05-14 07:43
Articles in Press	2022-05-14 07:43
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-04-30 01:57
Typeset the Manuscript	2022-06-14 08:34
Publish the Manuscript Online	2022-06-24 13:12

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Drug-induced autoimmune hepatitis: A minireview
Manuscript Source	Invited Manuscript
All Author List	Chin Kimg Tan, Danielle Ho, Lai Mun Wang and Rahul Kumar
Funding Agency and Grant Number
Corresponding Author	Rahul Kumar, FRCP, Assistant Professor, Gastroenterology and Hepatology, Changi General Hospital , 2 Simei Street 3, Singapore 529889, Singapore. rahul.kumar@singhealth.com.sg
Key Words	Drug-induced liver injury; Drug-induced autoimmune hepatitis; Autoimmune hepatitis; Review
Core Tip	Drug-induced autoimmune hepatitis is uncommon in clinical practice but may have devastating consequences. It is important to distinguish drug-induced autoimmune hepatitis from idiopathic autoimmune hepatitis as the former may not require prolong course of immunosuppressant. This minireview highlights the key differences between these two closely-linked entities.
Publish Date	2022-06-24 13:12
Citation	Tan CK, Ho D, Wang LM, Kumar R. Drug-induced autoimmune hepatitis: A minireview. World J Gastroenterol 2022; 28(24): 2654-2666
URL	https://www.wjgnet.com/1007-9327/full/v28/i24/2654.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i24.2654

Full Article (PDF)	WJG-28-2654.pdf
Full Article (Word)	WJG-28-2654.docx
Manuscript File	70494_Auto_Edited-JPY-Filipodia CL-LS.docx
Answering Reviewers	70494-Answering reviewers.pdf
Audio Core Tip	70494-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	70494-Conflict-of-interest statement.pdf
Copyright License Agreement	70494-Copyright license agreement.pdf
Peer-review Report	70494-Peer-review(s).pdf
Scientific Misconduct Check	70494-Bing-Yan JP-2.png
Scientific Editor Work List	70494-Scientific editor work list.pdf